Descriptor
| Behavior Change | 2 |
| Drug Therapy | 2 |
| Multiple Disabilities | 2 |
| Outcomes of Treatment | 2 |
| Adults | 1 |
| Behavior Disorders | 1 |
| Behavior Problems | 1 |
| Case Studies | 1 |
| Incidence | 1 |
| Medical Evaluation | 1 |
| Mental Disorders | 1 |
| More ▼ | |
Publication Type
| Journal Articles | 2 |
| Reports - Research | 2 |
Education Level
Audience
| Researchers | 2 |
Location
Laws, Policies, & Programs
Assessments and Surveys
What Works Clearinghouse Rating
Peer reviewedHammock, Ron G.; And Others – Journal of Autism and Developmental Disorders, 1995
Clozapine, a neuroleptic drug, was used to complete a 93-week double-blind crossover trial with a 40-year-old male having profound mental retardation and sensory impairments and displaying self-injurious behavior (SIB) patterns. Findings suggest that clozapine could be an effective pharmacological intervention for some cases of SIB. (DB)
Descriptors: Adults, Behavior Change, Case Studies, Drug Therapy
Friedman, Debra L.; And Others – American Journal on Mental Retardation, 1992
This study with 65 individuals with mental retardation and additional seizure and/or psychiatric or behavioral disorders found that 9.2 percent experienced medication (carbamazepine) side effects, ranging from irritability to mania. More side effects were experienced by individuals with behavioral or psychiatric disorders than by those with an…
Descriptors: Behavior Change, Behavior Disorders, Behavior Problems, Drug Therapy
